PAGNINI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.606
EU - Europa 2.570
AS - Asia 1.647
SA - Sud America 257
AF - Africa 49
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.169
Nazione #
US - Stati Uniti d'America 4.575
RU - Federazione Russa 1.080
SG - Singapore 442
PL - Polonia 407
CN - Cina 396
HK - Hong Kong 320
IE - Irlanda 271
IT - Italia 246
SE - Svezia 226
BR - Brasile 218
KR - Corea 171
VN - Vietnam 87
IN - India 81
FI - Finlandia 74
DE - Germania 68
GB - Regno Unito 68
JO - Giordania 46
AU - Australia 39
ID - Indonesia 22
FR - Francia 21
UA - Ucraina 21
AR - Argentina 19
AT - Austria 19
CA - Canada 18
ES - Italia 17
TR - Turchia 17
CH - Svizzera 16
CI - Costa d'Avorio 15
NL - Olanda 13
IQ - Iraq 12
ZA - Sudafrica 12
BD - Bangladesh 10
BE - Belgio 9
JP - Giappone 9
MX - Messico 7
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EC - Ecuador 5
MA - Marocco 5
PY - Paraguay 5
SC - Seychelles 5
UZ - Uzbekistan 5
KZ - Kazakistan 4
VE - Venezuela 4
BH - Bahrain 3
CL - Cile 3
CZ - Repubblica Ceca 3
IR - Iran 3
KE - Kenya 3
TN - Tunisia 3
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
LV - Lettonia 2
PA - Panama 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MU - Mauritius 1
NI - Nicaragua 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.169
Città #
Santa Clara 1.082
Fairfield 438
Warsaw 405
Ashburn 403
Singapore 292
Hong Kong 270
Dublin 266
Chandler 246
Dallas 199
Woodbridge 186
Cambridge 180
Seoul 171
Seattle 170
Beijing 158
Houston 158
Wilmington 151
Lawrence 101
Altamura 95
Ann Arbor 83
Princeton 79
Los Angeles 76
Hefei 66
Buffalo 55
Medford 52
Moscow 44
The Dalles 40
London 39
Boston 37
Munich 37
Mumbai 36
Florence 34
Melbourne 34
San Diego 32
New York 30
Shanghai 30
Ho Chi Minh City 27
Clifton 25
Pune 24
Boardman 21
Hanoi 19
Vienna 19
Jacksonville 18
Kent 18
Jakarta 17
Milan 17
Abidjan 15
Bern 15
São Paulo 15
Turku 15
Redondo Beach 14
Norwalk 13
Falls Church 12
Helsinki 12
Chennai 11
Paris 11
Hillsboro 10
Toronto 10
Barcelona 9
Johannesburg 9
Ankara 8
Brussels 8
Chicago 8
Dong Ket 8
Izmir 8
San Francisco 8
Tokyo 8
Brooklyn 7
Erbil 7
Guangzhou 6
Naples 6
Yubileyny 6
A Coruña 5
Campinas 5
Columbus 5
Denver 5
Frankfurt Am Main 5
Frankfurt am Main 5
Lettere 5
Rio de Janeiro 5
Tashkent 5
Amsterdam 4
Baku 4
Cagliari 4
Contagem 4
Council Bluffs 4
Lappeenranta 4
Menlo Park 4
Orem 4
Phoenix 4
Salvador 4
Stockholm 4
Thái Bình 4
Trieste 4
Akron 3
Andover 3
Belo Horizonte 3
Bengaluru 3
Cape Town 3
Casablanca 3
Cinisello Balsamo 3
Totale 6.357
Nome #
biologic therapy in children with enthesitis-related arthritis the fist year after disease onset 263
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 255
The intestinal microbiota in enthesitis-related arthitis 255
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 209
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 204
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 203
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 200
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports 193
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 185
Oral clonidine provocative test in the diagnosis of growth hormone deficiency in childhood: should we make the timing uniform? 184
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 181
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 177
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 177
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 168
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 166
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 159
Clinical features and outcome of Cogan syndrome. 147
The off-label use of anakinra in pediatric systemic autoinflammatory diseases 145
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 139
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 139
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 139
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 138
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 137
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 137
CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection 136
STAT3-confusion-of-function: Beyond the loss and gain dualism 135
Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review 134
Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment? 132
Sequential MR angiography in childhood primary angiitis of the CNS. 132
Ocular involvement in monogenic autoinflammatory disease: A systematic literature review 132
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 131
Distal extremity pain as a presenting feature of Fabry's disease. 129
Cervical arthritis as early manifestation of enthesitis-related arthritis complicated by uveitis 128
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 127
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 126
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity? 125
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 124
Treatment strategies for childhood noninfectious chronic uveitis: an update. 123
Acute hemorrhagic edema of infancy: 20‐year experience from an Italian tertiary referral center 122
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series 121
Development and retrospective validation of the juvenile spondyloarthritis disease activity index. 120
Utility of magnetic resonance imaging when following up sacroiliitis in enthesitis-related arthritis. 118
 A Rare Case of Neonatal Antiphospholipid Syndrome 117
 Possible Correlation Between Congenital Heart Block and Autoimmune Hearing Loss 115
Circulating levels of vaspin and omentin, two novel adipokines, in juvenile idiopathic arthritis 115
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis. 112
Oral clonidine provocative test in the diagnosis of growth hormone deficiency (GHD) in childhood: should we make the timing uniform? 112
Biological drugs in paediatric COVID-19 infection: what patients, which drug, how much and how long 112
Final height in females and males with precocious puberty after GnRHa treatment 109
BONE STATUS OF CHILDREN BORN FROM MOTHERS WITH AUTOIMMUNE DISEASES TREATED DURING PREGNANCY WITH LOW MOLECULAR WEIGHT HEPARIN AND/OR PREDNISONE 108
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. 105
Cutaneous polyarteritis nodosa and common variable immunodeficiency: a previously unreported association. 105
Cogan Syndrome: a rare but severe vasculitis in pediatric age 103
Distal limb pain as presenting feature of Fabry disease. 103
Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure 100
Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments 100
Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey 98
Kawasaki disease 2013: Clinical cases and new issues 97
Pathogenesis of juvenile idiopathic arthritis: A review of the possible role of different synovial fluid T lymphocyte subsets 97
Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms 96
What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis? 89
Pathogenesis of Juvenile Idiopathic Arthritis: A Review of the Possible Role of Different Synovial Fluid T Lymphocyte Subsets 83
Increased percentages of tumor necrosisfactor-alpha+/interferon-gamma+ lymphocytes and calprotectin+/tumor necrosisfactor-alpha+ monocytes in patients with acute Kawasaki disease 80
Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis. 77
Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation. 74
Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. 73
null 72
Usefulness of autoantibodies against inner ear antigens for the diagnosis 67
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease. 67
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features 51
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study 47
Totale 9.279
Categoria #
all - tutte 27.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021215 0 0 0 0 0 35 19 37 29 57 18 20
2021/2022518 4 79 69 34 8 12 15 45 17 17 68 150
2022/20231.238 111 276 58 83 72 214 167 59 127 11 31 29
2023/2024456 14 44 71 18 36 109 24 82 12 18 21 7
2024/20253.074 121 308 167 455 950 408 29 204 129 60 123 120
2025/20261.913 361 532 314 295 385 26 0 0 0 0 0 0
Totale 9.279